• SENSEX 71,924.68
    -547.65 (--0.76%)
  • BANKNIFTY 54,918.00
    -338.65 (--0.61%)
Back

Corporate News

GlaxoSmithKline Pharmaceuticals Limited reports certificate compliance with SEBI regulations
12-Oct-2026, 05:04

GlaxoSmithKline Pharmaceuticals Limited informed the BSE Limited and the National Stock Exchange of India Limited that it has received a certificate from Kfin Technologies Limited, its Registrar and share Transfer Agent, for the quarter ended September 30, 2026, in compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.